Cribl Supercharges Incident Response in Amazon Security Hub with Open Cybersecurity Schema Framework (OCSF) Support
Enhanced capability in Cribl Stream transforms disparate security findings into a standardized…
Vantage Foundation Donates HK$1 Million to Support Residents Affected by Hong Kong Fire
HONG KONG, Nov. 29, 2025 /PRNewswire/ -- Vantage Foundation has donated HK$1 million…
Press Release: Sanofi and Regenerons Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the…
Burn Blend Releases Comprehensive Gelatin Trick Recipe Based Protocol Guide in Response to Rising Public Interest in Weight-Management Methods
New York City, NY, Nov. 23, 2025 (GLOBE NEWSWIRE) -- The organization…
Canadian Red Cross sending emergency medical clinic to Jamaica
Humanitarian experts deploying to help people impacted by Hurricane Melissa November 10,…
ECW Announces US$2 Million Grant for Flood-Affected Children in Pakistan
First Emergency Response grant will reach 34,483 students through local consortium led…
Miggo Security Receives Frost & Sullivan’s 2025 Global New Product Innovation Recognition for Advancing Application Security Leadership
The company is redefining application security and AI Runtime Protection through its…
Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business
COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the…
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM),…
Subcutaneous RYBREVANT(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer
Responses were rapid and durable, and tumour shrinkage was observed in 82…